BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12114434)

  • 1. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors.
    Chen G; Gharib TG; Huang CC; Thomas DG; Shedden KA; Taylor JM; Kardia SL; Misek DE; Giordano TJ; Iannettoni MD; Orringer MB; Hanash SM; Beer DG
    Clin Cancer Res; 2002 Jul; 8(7):2298-305. PubMed ID: 12114434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein profiles associated with survival in lung adenocarcinoma.
    Chen G; Gharib TG; Wang H; Huang CC; Kuick R; Thomas DG; Shedden KA; Misek DE; Taylor JM; Giordano TJ; Kardia SL; Iannettoni MD; Yee J; Hogg PJ; Orringer MB; Hanash SM; Beer DG
    Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13537-42. PubMed ID: 14573703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the future for people with lung cancer.
    Xie Y; Minna JD
    Nat Med; 2008 Aug; 14(8):812-3. PubMed ID: 18685594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling in sinonasal adenocarcinoma.
    Tripodi D; Quéméner S; Renaudin K; Ferron C; Malard O; Guisle-Marsollier I; Sébille-Rivain V; Verger C; Géraut C; Gratas-Rabbia-Ré C
    BMC Med Genomics; 2009 Nov; 2():65. PubMed ID: 19903339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analyses identify HK1 and ATP5A to be overexpressed in distant metastases of lung adenocarcinomas compared to matched primary tumors.
    Pasternack H; Polzer M; Gemoll T; Kümpers C; Sauer T; Lazar-Karsten P; Hinrichs S; Bohnet S; Perner S; Dressler FF; Kirfel J
    Sci Rep; 2023 Nov; 13(1):20948. PubMed ID: 38016997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the proteomic expression in patients with complicated parapneumonic pleural effusion.
    Wu X; Yang W; Gou XH; Xu XY; Lu N; Jian SN; Han YJ; Lv TS; Luo LZ
    Arch Med Sci; 2023; 19(5):1270-1280. PubMed ID: 37732066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Triosephosphate Isomerase Is a Potential Target in Cancer Due to Commonly Occurring Post-Translational Modifications.
    Enríquez-Flores S; De la Mora-De la Mora I; García-Torres I; Flores-López LA; Martínez-Pérez Y; López-Velázquez G
    Molecules; 2023 Aug; 28(16):. PubMed ID: 37630415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moonlight functions of glycolytic enzymes in cancer.
    Shegay PV; Shatova OP; Zabolotneva AA; Shestopalov AV; Kaprin AD
    Front Mol Biosci; 2023; 10():1076138. PubMed ID: 37449059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPA1, an energy metabolism initiator, plays an important role in the progression of malignant tumors.
    Wang S; Wei J; Li S; Luo Y; Li Y; Wang X; Shen W; Luo D; Liu D
    Front Oncol; 2022; 12():1012090. PubMed ID: 36505776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome derangement in malignant epithelial cells and its stroma following exposure to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
    Marshall K; Twum Y; Gao W
    Arch Toxicol; 2023 Mar; 97(3):711-720. PubMed ID: 36434399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of IgM antigens from mammary tissue under pre- and post-cancer conditions using the MMTV-PyVT mouse model.
    Hernández Ávila R; Díaz-Zaragoza M; Ostoa-Saloma P
    PeerJ; 2022; 10():e14175. PubMed ID: 36275472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA FOXP4-AS promotes the progression of non-small cell lung cancer by regulating the miR-3184-5p/EIF5A axis.
    Li D; Li Z; YanFei W; Wang Y; Shi J; Liu C; Qu L; Deng S; Xiong D
    J Tissue Eng Regen Med; 2022 Apr; 16(4):335-345. PubMed ID: 34921595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPA1 Promotes Breast Cancer Proliferation and Metastasis Through PI3K/AKT/GSK3β Signaling Pathway.
    Guo C; Li S; Liang A; Cui M; Lou Y; Wang H
    Front Cell Dev Biol; 2021; 9():730558. PubMed ID: 34595179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers.
    Katzendorn O; Peters I; Dubrowinskaja N; Tezval H; Tabrizi PF; von Klot CA; Hennenlotter J; Lafos M; Kuczyk MA; Serth J
    BMC Cancer; 2021 Apr; 21(1):444. PubMed ID: 33882870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization and Anti-Cancer Properties of Fluoromethylketones as Covalent Inhibitors for Ubiquitin C-Terminal Hydrolase L1.
    Krabill AD; Chen H; Hussain S; Hewitt CS; Imhoff RD; Muli CS; Das C; Galardy PJ; Wendt MK; Flaherty DP
    Molecules; 2021 Feb; 26(5):. PubMed ID: 33668938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the intestinal mucosal proteome in cats with inflammatory bowel disease and alimentary small cell lymphoma.
    Marsilio S; Dröes FC; Dangott L; Chow B; Hill S; Ackermann M; Estep JS; Lidbury JA; Suchodolski JS; Steiner JM
    J Vet Intern Med; 2021 Jan; 35(1):179-189. PubMed ID: 33471936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Quest for New Cancer Diagnosis, Prognosis and Prediction Biomarkers and Their Use in Biosensors Development.
    Ramirez-Valles EG; Rodríguez-Pulido A; Barraza-Salas M; Martínez-Velis I; Meneses-Morales I; Ayala-García VM; Alba-Fierro CA
    Technol Cancer Res Treat; 2020; 19():1533033820957033. PubMed ID: 33107395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequenced Combinations of Cisplatin and Selected Phytochemicals towards Overcoming Drug Resistance in Ovarian Tumour Models.
    Althurwi SI; Yu JQ; Beale P; Huq F
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic analysis of the monkey hippocampus for elucidating ischemic resistance.
    Mori Y; Oikawa S; Kurimoto S; Kitamura Y; Tada-Oikawa S; Kobayashi H; Yamashima T; Murata M
    J Clin Biochem Nutr; 2020 Sep; 67(2):167-173. PubMed ID: 33041514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma.
    Gillette MA; Satpathy S; Cao S; Dhanasekaran SM; Vasaikar SV; Krug K; Petralia F; Li Y; Liang WW; Reva B; Krek A; Ji J; Song X; Liu W; Hong R; Yao L; Blumenberg L; Savage SR; Wendl MC; Wen B; Li K; Tang LC; MacMullan MA; Avanessian SC; Kane MH; Newton CJ; Cornwell M; Kothadia RB; Ma W; Yoo S; Mannan R; Vats P; Kumar-Sinha C; Kawaler EA; Omelchenko T; Colaprico A; Geffen Y; Maruvka YE; da Veiga Leprevost F; Wiznerowicz M; Gümüş ZH; Veluswamy RR; Hostetter G; Heiman DI; Wyczalkowski MA; Hiltke T; Mesri M; Kinsinger CR; Boja ES; Omenn GS; Chinnaiyan AM; Rodriguez H; Li QK; Jewell SD; Thiagarajan M; Getz G; Zhang B; Fenyö D; Ruggles KV; Cieslik MP; Robles AI; Clauser KR; Govindan R; Wang P; Nesvizhskii AI; Ding L; Mani DR; Carr SA;
    Cell; 2020 Jul; 182(1):200-225.e35. PubMed ID: 32649874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.